Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock
NCT02120404
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Septic Shock
Interventions
DRUG:
Esmolol administration
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
[object Object]